A PEDF-Derived Peptide Inhibits Retinal Neovascularization and Blocks Mobilization of Bone Marrow-Derived Endothelial Progenitor Cells
Figure 3
Systemic injection of PEDF-34 reduced ischemia-induced retinal neovascularization. The graph represents the average number of preretinal (vitreous) vascular cells in OIR mice treated with BSA or PEDF-34. (mean ± SEM, BSA . PEDF-34 ).